Pharmacokinetic profile of levetiracetam
Top Cited Papers
- 2 February 2000
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 85 (2), 77-85
- https://doi.org/10.1016/s0163-7258(99)00052-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and InhibitorsDrug Metabolism Reviews, 1997
- The Clinical Pharmacokinetics of the Newer Antiepileptic DrugsClinical Pharmacokinetics, 1996
- A Micromethod for the Determination of the New Antiepileptic Drug Levetiracetam (ucb LO59) in Serum or Plasma by High Performance Liquid ChromatographyTherapeutic Drug Monitoring, 1996
- Clinical pharmacokinetics of new antiepileptic drugsPharmacology & Therapeutics, 1995
- The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranesEuropean Journal of Pharmacology, 1995
- Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsyEpilepsy Research, 1995
- Section Review Central & Peripheral Nervous Systems: New anti-epileptic drugsExpert Opinion on Investigational Drugs, 1995
- Some Aspects of Prognosis in the Epilepsies: A ReviewEpilepsia, 1993
- Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and ratsEuropean Journal of Pharmacology, 1993
- Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsyAnnals of Neurology, 1991